Shire's Baxalta bid: Poison pill or antidote? By: CNBC.com News August 05, 2015 at 03:54 AM EDT Shire, the specialty pharma company, may need to find an antidote for a poison pill before it can win shareholders in Baxalta over to its $30bn bid. Read More >> Related Stocks: Baxter International